FORA Capital LLC Invests $2.35 Million in MetLife, Inc. $MET

FORA Capital LLC purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 29,190 shares of the financial services provider's stock, valued at approximately $2,347,000.

• 3 Finance Stocks Leaving Coal in Investors Stockings

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Brighton Jones LLC increased its holdings in shares of MetLife by 9.0% during the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after buying an additional 351 shares in the last quarter. HighTower Advisors LLC grew its position in MetLife by 8.7% during the 1st quarter. HighTower Advisors LLC now owns 180,632 shares of the financial services provider's stock worth $14,503,000 after acquiring an additional 14,433 shares during the last quarter. Horizon Investments LLC increased its holdings in MetLife by 7.8% in the 1st quarter. Horizon Investments LLC now owns 32,342 shares of the financial services provider's stock worth $2,578,000 after purchasing an additional 2,351 shares in the last quarter. Aberdeen Group plc boosted its position in MetLife by 8.3% during the 1st quarter. Aberdeen Group plc now owns 1,022,274 shares of the financial services provider's stock worth $81,347,000 after buying an additional 78,069 shares during the period. Finally, American Century Companies Inc. grew its holdings in MetLife by 21.8% during the 1st quarter. American Century Companies Inc. now owns 1,288,497 shares of the financial services provider's stock worth $103,453,000 after acquiring an additional 230,269 shares during the last quarter. Institutional investors own 94.99% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Morgan Stanley raised their price target on shares of MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Wells Fargo & Company lowered their target price on MetLife from $96.00 to $92.00 and set an "overweight" rating for the company in a research report on Friday, November 7th. Cowen reiterated a "buy" rating on shares of MetLife in a research report on Friday, August 22nd. Barclays increased their price target on MetLife from $93.00 to $98.00 and gave the company an "overweight" rating in a research note on Wednesday, October 8th. Finally, Piper Sandler lowered MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price objective on the stock. in a research note on Friday, September 19th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, MetLife currently has a consensus rating of "Moderate Buy" and a consensus target price of $94.60.

• 2 Insurance Stocks Poised For Major Breakouts

Get Our Latest Stock Analysis on MET

MetLife Stock Performance

MET stock opened at $82.08 on Friday. The firm has a market cap of $54.08 billion, a PE ratio of 15.46, a price-to-earnings-growth ratio of 0.79 and a beta of 0.76. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. The stock has a 50-day moving average price of $78.47 and a 200-day moving average price of $78.76. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $88.09.

• MarketBeat Week in Review – 8/21 - 8/25

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.30 by $0.07. The business had revenue of $12.46 billion during the quarter, compared to analysts' expectations of $18.64 billion. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The firm's revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.95 earnings per share. As a group, equities research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th were paid a $0.5675 dividend. The ex-dividend date was Tuesday, November 4th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife's payout ratio is currently 42.75%.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

• Five stocks we like better than MetLife
• The Top 3 Healthcare Dividend Stocks to Buy and Hold
• Disney's $1 Billion Deal Brings Its Magic to OpenAI
• REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today
• Why Amazon Could Be a $300 Stock Within Weeks
• How to Effectively Use the MarketBeat Ratings Screener
• Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here